Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst
On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter 2025 revenues of $5.07 billion, beating the consensus estimate of $4.97 billion.
Benzinga ·